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Abstract 
 
Carbohydrate – protein interactions play very important roles in many biological functions. For 
example, cell-cell recognition, cell adhesion, signal transduction, fertilization, infection and 
inflammation etc. The better understanding of these binding activities could help to develop 
more cutting-edge treatment strategies. With the progress of science and technology, more 
and more new structural analyses of carbohydrate-protein interactions are published. Within 
this thesis, the focus was on analyzing carbohydrate – protein interactions under special 
consideration of LPS fragments, hyaluronic acid, sulfated saccharides and sialic acids, with 
biophysical (NMR, X-ray, SPR), biochemical and cell-biological methods. The main findings 
are as follows.  
In chapter I, the SPR (Surface Plasmon Resonance) study indicates the saccharide part of 
LPS determines the specific interactions with lysozymes. For this reason we focus on a 
defined building block of a LPS glycosidic chain and started with the disaccharide fragment of 
Klebsiella pneumoniae. The data mining analysis of protein-carbohydrate complexes in the 
Protein Data Bank (PDB) with GlyVicinity revealed that Trp (W), Tyr (Y), Asn (N) and Asp (D) 
are the most overrepresented amino acids in the vicinity of α-D-Galp residues. Furthermore, 
the NMR studies suggested that mixtures of human lysozyme (HL) and the disaccharide 
building block (repeating unit) of the Klebsiella pneumoniae LPS yielded only at pH 5.5 
observable changes in the chemical shift values. The two helices and in particular the catalytic 
residue Glu35 respond to the addition of the disaccharide. In addition, a change of chemical 
shift is also observed on the β-domain in the center of the first strand (Asn44). A strong 
reduction of line broadening for Hal shift values. The two helices and in particular the catalytic 
residue Glu35 respond to the addition of the disaccharide. In abohydrate chain packing close 
to the A, B, C and D binding sites of HL, which primarily occurred through residue-specific, 
direct or water-mediated hydrogen bonds and hydrophobic contacts. Overall, these results 
support a crucial role of the Glu35/Asp53/Trp63/Asp102 residues in HL binding to the 
tetrasaccharide. These observations suggest an unknown glycan-guided mechanism that 
underlies recognition of the bacterial cell wall by lysozyme and may complement the HL 
immune defense function. 
In chapter II, data mining approaches for a general analysis of all protein - sialic acid 
complexes in the Protein Data Bank (PDB) showed that Arg (R), Tyr (Y) and Trp (W) residues 
are the most frequently occurring amino acid residues in the vicinity of bound sialic acids. 
When focusing on sulfate groups of glycan, the data mining approach shows that Lys (K) is 
 	
overrepresented in the vicinity of this functional group. Besides Lys (K) residues, Arg (R) 
residues are likely to primarily bind such residues due to their vicinity preferably to sulfate 
groups and uronic acid in the corresponding complexes found in the protein data bank. Our 
data mining approach was supported by NMR experiments. Our NMR results clearly show that 
the addition of polySia to the MARCKS-ED peptide causes spectral changes, suggesting that 
protons from the MARCKS-ED peptide are involved in binding with polySia. In addition, NMR 
experiments using SHL-1 or the human α-defensins HNP1,2,3 as receptors and polySia 
fragments from colominic acid used as ligands revealed that three aromatic amino acid 
residues and an Arg residue play a major role in carbohydrate binding. In our studies we were 
able to combine the structural analysis with cell-biological experiments. Compared to a control 
group (poly-L-lysine), the sulfated polysaccharides from algae show a statistically significant 
enhancement of neurite outgrowth at concentrations from 0.0001 to 0.1 mg/ml. However, at 
concentrations that were higher than 1 mg/ml, the sulfated polysaccharides exhibit inhibitory 
effects on neurite outgrowth.  
In chapter III, a new ImageJ analyzing method was developed and successfully applied to 
determine the molecular weight distribution of hyaluronic acid (HA). By horizontal agarose gel 
electrophoresis, compared with control synovial fluid (SF), the molecular weight of hyaluronic 
acid shifted toward the lower range in osteoarthritis and rheumatoid arthritis SF. The 
percentage of HA in the upper range of 3.1-6.1 MDa was highest in control SF, followed by 
early-stage osteoarthritis and late-stage osteoarthritis, and bottoming in rheumatoid arthritis. In 
the lower ranges of 0.5-1.1 MDa and <0.5 MDa, the relative HA concentrations were 
significantly higher in early-stage osteoarthritis, late-stage osteoarthritis, and rheumatoid 
arthritis SF versus control SF. 
 
 
 
 
 
 
 
 
 
 
 
 
 	
Zusammenfassung  
 
Kohlenhydrat - Protein - Wechselwirkungen spielen bei vielen biologischen Funktionen eine 
sehr wichtige Rolle. Beispiele sind die Zell-Zell-Erkennung, die Zelladhäsion, die 
Signaltransduktion, sowie Fertilisationsprozesse, die Infektions- und die 
Entzündungsbekämpfung. Das bessere Verständnis dieser biochemischen Aktivitäten kann 
dazu beitragen, innovative Behandlungsstrategien zu entwickeln. Der Fortschritt von 
Wissenschaft und Technik ermöglicht die Aufklärung neuer Strukturen von Kohlenhydrat-
Protein-Komplexen. Im Rahmen dieser Arbeit wurde der Schwerpunkt auf die Analyse von 
Kohlenhydrat-Protein-Wechselwirkungen unter besonderer Berücksichtigung von LPS 
(Lipopolysaccharid) - Fragmenten, Hyaluronsäure, sulfatierten Sacchariden und Sialinsäuren 
mit biophysikalischen (NMR, Röntgen, SPR) und biochemischen Methoden gelegt. Die 
wichtigsten Ergebnisse sind in den folgenden Textpassagen zusammengefasst. 
In Kapitel I wird mit Hilfe einer die SPR-Studie gezeigt, dass der Saccharidteil von LPS 
spezifische Wechselwirkungen mit Lysozymen eingeht. Aus diesem Grund wurde der Fokus 
auf einem definierten Baustein einer LPS-glykosidischen Kette (dem Disaccharidfragment von 
Klebsiella pneumoniae.) gelegt. Die Analyse von Protein-Kohlenhydrat-Wechselwirkungen in 
der Proteindatenbank (PDB) erfolgte mit dem Data-Mining-Programm GlyVicinity und zeigte, 
dass Trp (W), Tyr (Y), Asn (N) und Asp (D) Reste die am häufigsten überrepräsentierten 
Aminosäuren in der Nähe von α-D-Galp-Saccharideinheiten sind. Weiterhin ging aus den 
NMR-Studien hervor, dass Mischungen aus HL (human lysozyme) und dem 
Saccharidbaustein (Wiederholungseinheit) der Klebsiella pneumoniae LPS Kohlenhydratkette 
nur bei zu pH 5.5 beobachtbaren Veränderungen der chemischen Verschiebungswerte 
führten. Die beiden Helices und insbesondere der katalytische Rest Glu35 reagieren auf die 
Addition des Disaccharids. Zusätzlich wird eine Änderung der chemischen Verschiebung auch 
auf der β-Domäne in der Mitte des ersten Strangs beobachtet (Asn44). Es ergibt sich eine 
signifikante Verringerung der Linienverbreiterung für Hε1 von Trp109 in Gegenwart des 
Saccharids. Die Kristallstruktur des HL-Tetrasaccharid-Komplexes stellt die 
Kohlenhydratkettenpackung nahe bei die A, B, C und D Bindungsstellen von HL dar, die 
primär durch restspezifische, direkte oder wasservermittelte Wasserstoffbrücken und 
hydrophobe Kontakte gebildet wird. Insgesamt unterstützen diese Ergebnisse, die Annahme, 
dass die Reste Glu35 / Asp53 / Trp63 / Asp102 eine entscheidende Rolle bei der der HL-
Bindung an das Tetrasaccharid spielen. 
 
 	
Diese Beobachtungen deuten auf einen unbekannten Glycan-geführten Mechanismus hin, der 
der Erkennung der bakteriellen Zellwand durch Lysozym unterliegt und die HL-
Immunabwehrfunktion ergänzen kann. 
In Kapitel II haben Data Mining - Ansätze für eine allgemeine Analyse aller Protein - 
Sialinsäure - Komplexe in der Protein Data Bank (PDB) gezeigt, dass Arg (R), Tyr (Y) und Trp 
(W) die am häufigsten vorkommende Aminosäure - Reste in der Nähe von gebundenen 
Sialinsäuren sind. Bei einer Fokussierung auf Sulfatgruppen von Glycan zeigt der Data-
Mining-Ansatz, dass Lys (K) in der Nähe dieser funktionellen Gruppe überrepräsentiert ist. 
Neben Lys (K) - Resten sind Arg (R) - Reste überrepräsentiert und zwar aufgrund ihrer 
Fähigkeit bevorzugt Sulfatgruppen und Uronsäure zu binden. Diese Data-Mining Ergebnisse 
unterstützen die Interpretation unserer NMR Daten. Unsere NMR-Resultate zeigen in 
deutlicher Weise, dass die Bindung von polySia an das MARCKS-ED-Peptid spektrale 
Veränderungen bewirkt, was darauf hindeutet, dass Protonen aus dem MARCKS-ED-Peptid 
an der Bindung mit polySia beteiligt sind. Darüber hinaus belegen die Ergebnisse aus den 
NMR-Experimenten mit dem Spinnenlektin SHL-1 sowie den humanen α-Defensinen 
HNP1,2,3, die als Sialinsäure-Minirezeptoren dienen, dass polySia-Fragmente aus 
Colominsäure spezifisch bindende Liganden sind. Drei aromatische Aminosäurereste und ein 
Arg-Rest spielen eine wichtige Rolle bei der Sialinsäurbindung. Es war uns möglich die 
strukturbiologischen Resultate mit zellbiologischen Ansätzen zu verbinden. Im Vergleich zu 
einem MARCKS-ED-Kontrollpeptid (Poly-L-Lysin) bewirken sulfatierte Polysaccharide aus 
Algen eine statistisch signifikante Verbesserung des Neuritenwachstums bei Konzentrationen 
von 0,0001 bis 0,1 mg / ml. Jedoch zeigen die sulfatierten Polysaccharide. Bei 
Konzentrationen, die höher als 1 mg / ml sind, hemmende Wirkungen auf das Auswachsen 
von Neuriten. 
In Kapitel III wurde ein neues Image-J-Analyseverfahren entwickelt und erfolgreich angewandt, 
um die Molekulargewichtsverteilung von Hyaluronsäure (HA) zu bestimmen. Durch horizontale 
Agarosegelelektrophorese, die mit Kontroll-Synovialflüssigkeit (SF) verglichen wurde, 
verschob sich das Molekulargewicht (MW) von Hyaluronsäure (HA) in Richtung des unteren 
Bereichs, der für Osteoarthritis und rheumatoider Arthritis signifikant ist. Der prozentuale 
Anteil von HA im oberen Bereich von 3.1-6.1 MDa war am höchsten in der Kontrollgruppe, 
gefolgt von Daten einer frühzeitigen Osteoarthritis und Daten die für eine späte Osteoarthritis 
und/ oder eine rheumatoide Arthritis sprechen. In den unteren Bereichen der Gele von 0,5-1,1 
MDa und <0,5 MDa waren die relativen HA-Konzentrationen einer frühen Osteoarthritis sowie 
der späten Osteoarthritis und der rheumatoiden Arthritis in Bezug auf die untersuchte SF 
 	
gegenüber der SF Kontrolle signifikant höher. Mit Hilfe des Image-J-Analyseverfahren konnte 
so der optimale Analysebericht in den angefertigten Gelen eingegrenzt bzw. bestimmt werden. 
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Chapter I: Interaction studies between carbohydrate residues of bacterial 
lipopolysaccharides (LPS) and lysozymes as revealed by a combination of 
biophysical methods under special consideration of the pH conditions 
 
1.  Introduction 
 
1.1 Lipopolysaccharide from Klebsiella pneumoniae 
Klebsiella pneumoniae, also called Friedländer’s Bacillus, is a Gram-negative, encapsulated, 
cylindrical rod and non-motile bacterium of the Enterobacteriaceae family, which was first 
isolated from the lungs of patients who died from pneumoniae and was described by German 
pathologist Carl Friedländer in 1882. Then it was renamed by Klebsiella in 1886 in honor of 
the German bacteriologist Edwin Klebs (Fig. 1)1-3. As a well-known causative pathogen of 
various severe diseases, it accounts for pneumonia, urinary tract infections, osteomyelitis, 
septicemia, as well as wound infections and pyogenic liver abscesses, etc.4,5. As leading 
cause of nosocomial opportunistic infections, Klebsiella pneumoniae peculiarly infects 
immunocompromised patients, suffering from chronic alcoholism, diabetes mellitus, chronic 
pulmonary obstruction, malignancy, liver disease, and people with debilitating diseases6,7. The 
β-lactam drugs have been effectively used for treating Klebsiella pneumoniae infections. 
However, since initially discovered in 1996 in North Carolina, the strains of carbapenemase-
producing Klebsiella pneumoniae (CPKP) are only susceptible to limited antibiotics, and 
resulted in high mortality rates of more than 50%. Moreover, they have widely disseminated in 
the United State and worldwide during the last decades8-11. Therefore, the development of 
new alternative therapeutic strategies is urgently required. 
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Fig. 1. Scanning electron graph of Klebsiella pneumoniae. Janice Carr/Centers for Disease Control and 
Prevention (CDC) (Image Number: 6834) 
 
Lipopolysaccharide (LPS), also known as endotoxin that is localized at the surface of almost 
all Gram-negative bacteria (Fig. 2),  is a major constituent part of the outer membrane of 
Klebsiella pneumonia. It plays a crucial role in keeping the structural integrity and stability of 
the microbacillary membrane, and therefore provides the protection for Gram-negative 
bacteria from attack (e.g. bile salts and lipophilic antibiotics)12. LPS can elicit host defense 
system responses and acts as the endotoxin causing a diversity of pathophysiologic reactions, 
including fever, shock, hypotension, disseminated intravascular coagulation, and 
leukocytosis13. Together with the capsular polysaccharide (CPS), they are important factors in 
the pathogenicity of Klebsiella pneumonia infection and are responsible for pneumonia and 
bacteremia14-16. LPS is composed of three kinds of structural domains: the long chain O 
antigenic polysaccharide (O-PS; O-antigen), the core oligosaccharide (OS), and lipid A. The 
O-antigen is the outermost component of LPS. Among clinical Klebsiella pneumonia isolates 
from different sources and countries, the O1 antigen is the most prevalent O-antigen17,18. It 
has been reported to be expressed on the surface of most strains, and the antibodies against 
the O1 antigen can protect animal models from Klebsiella pneumonia infection19,20. The O1 
antigen contains two different O-PS components，D-galactan I and D-galactan II (Fig. 3a)21,22. 
The repeating unit, the disaccharide [-3)-β-D-Galf-(1-3)-α-D-Galp-(1-] was identified as the 
building block of the D-galactan I (Fig. 3b). It has been artificially synthesized by Nikolay E. 
Nifantiev and his colleagues23. In our study, we utilized this synthetic di- and tetrasaccharide 
as the binding ligand to analyse the interaction properties of Klebsiella pneumonia D-galactan 
I with human lysozyme. 
 	 3	
 
 
 
Fig. 2. Lipopolysaccharide (LPS) of Gram-negative bacteria24.  
 
 
                                         a 
 
 
 
                                         b 
 
 
 
Fig. 3. a The repeating unit structures of the Klebsiella pneumoniae O1 LPS consists of two structurally different 
O-polysaccharides, named D-galactan I and D-galactan II21. b Structure of synthetic di- and tetrasaccharides 
related to the glycan chain of the D-galactan I lipopolysaccharide (LPS) from Klebsiella pneumoniae. 
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1.2 Lysozymes 
Lysozymes also named as muraminidases of the innate immune system are the lytic enzymes 
which destroy the peptidoglycans of bacterial cell wall via hydrolysis of β-(1,4)-glycosidic 
bonds. The antimicrobial activity of lysozymes explains the great interest in their structure and 
function both for pharmaceutical applications and for food preservation25. Lysozymes are 
occurring in most living organisms. In the animal kingdom three types of lysozymes are 
distinguished according to amino acid sequence and biochemical properties: c-type (chicken), 
g-type (goose) and i-type (invertebrate)26. C-type lysozymes are found in mammals, birds, 
reptiles, fish and insects etc.; they consist of ~129 residues, including four conserved disulfide 
bonds, and form two domains, one built from α-helices and one containing a β-sheet (Fig. 4)27.  
The structure of hen egg white lysozyme was among the first protein crystal structures to be 
determined28 and, similarly, this enzyme was among the earliest NMR structures29. Since then 
many X-ray, NMR and other studies have been performed to characterise the structure, 
dynamics, folding (and misfolding) properties and function of various lysozymes. Of particular 
interest in food and health related applications are the adaptations of lysozymes to different 
environments. Thus, while mammals typically show high concentration of lysozyme in the 
respiratory tract and in milk, birds often exploit lysozyme as an antimicrobial agent in eggs, 
and fish on the surface of their skin and in the gastrointestinal tract26. C-type lysozymes such 
as human lysozyme (HL) or hen egg white lysozyme (HEWL) all share a conserved sequence 
(with 30% or higher identity) with strictly conserved disulfide bridges, and similar fold with 
helices A (residues 5-14), B (25-35), C (90-99) and D (110-116) in the α-domain, and a three-
stranded antiparallel β-sheet (42-46, 51-56, 59-61) in the β-domain (Fig. 4)28,29. An inter-
domain cleft contains six binding pockets (labelled A-F in Fig. 4), with the strictly conserved 
catalytic residue Glu35 located between the sites D and E30. Details of the enzymatic 
mechanism have been described for HEWL31 and involve a covalent intermediate with another 
strictly conserved residue, Asp52, which is provided by the α-domain. This mechanism 
requires residue Glu35 to be protonated, and indeed its pKa was found to be unusually high: 
6.8 for HL and 5.9 for HEWL32. 
The structural variations between 15 different c-type lysozymes obtained from the Protein 
Data Bank (PDB)33 are small. The average RMSD value between all structure pairs, 
calculated for the backbone of 104 residues, is 0.9 Å (these calculations exclude 
insertions/deletions, as well as 12 residues in loops adjacent to the latter). The most different 
structures belong to 3 insect lysozymes that differ by ~1.2 Å RMSD from the other 12 
proteins34. The more than 20 structures of human lysozymes found in the PDB are overall 
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even more similar (exceptions are due to perturbations by covalently bound ligands or 
originating from temperature variations). Nonetheless, it has been noticed for HEWL that the 
α-domain exhibits increased flexibility when compared to the β-domain, e.g. from studies 
varying temperature35 or pressure36. Furthermore, a crystal structure of HL with (non-covalent) 
binding of a tetrasaccharide plus a disaccharide in subsites A-D and E-F, respectively, shows 
a measurable movement of helix D, which was described as a ‘closing’ movement leading to 
tighter lysozyme-ligand interactions. NMR relaxation measurements have shown that the 
dynamic response indeed varies upon binding of a trisaccharide near the active site (residue 
100-115, i.e. helix D plus preceding loop) in HL and HEWL37 and the authors suggest that 
ligand binding entails immobilisation of interacting residues and the ensuing penalty is 
compensated by increased flexibility of other residues. Other NMR studies comparing human 
lysozyme structures at different temperatures (35°C and 4°C) report that high and low 
temperature induces ‘closing’ and ‘opening’ of the binding cleft, respectively38. 
Besides the presence of interacting ligands and the influence of temperature, pH is also an 
important determinant for the structure of lysozymes. Thus, for example, deprotonation of 
Glu35 completely inactivates the enzyme31. Structure expansion as a function of pH, in 
particular far from the isoelectric point, has been reported for HEWL. An interesting application 
of the pH response of lysozymes is their potential use as “valves” in nanoparticles allowing 
pH-controlled release of guest molecules39. Comparison of surfaces of various c-type 
lysozymes indicates modulation of the binding affinity to polysaccharides, in particular in sites 
A-D, by changes of the electrostatic potential.  
 
 
Fig. 4. Structure of human lysozyme (HL; PDB code 1LZS) with selected residues (Glu35, Asp53, Trp109). 
Binding sites A – F are indicated by letters in green circles, helices are colored as follows: A violet, B magenta, C 
red and D orange. In the orientation shown, the α-domain is to the right of the binding cleft, the β-domain to the 
left27. 
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1.3 Lysozyme against Klebsiella pneumoniae infection 
The lysozymes from mice, lysozyme M and lysozyme P, have been assessed and showed the 
ability to directly kill the K. pneumonia in vitro. The further in vivo research has elucidated that 
the enhanced expression of lysozyme in the airways of transgenic mice reduced bacterial 
burden and increased survival rate of mice, which were intratracheally infected by K. 
pneumoniae. Whereas targeting knockout the lysozyme M gene of mice led to lower effect on 
K. pneumoniae killing and significantly increased susceptibility to K. pneumoniae infection40. 
Moreover, intraperitoneal administration of lysozyme could also decrease the pathology 
resulting from a Klebsiella pneumoniae infection in mice41. These results suggest that 
lysozyme plays a very crucial role against Klebsiella pneumoniae infection and could be 
considered as a very promising pharmaceutical agent. 	
2. Experimental research 
 
2.1 Research topics and methods 
In order to reveal the specific non-enzymatic carbohydrate-protein interactions between 
building blocks of the glycan chain from K. pneumoniae and human as well as hen egg white 
lysozyme, we performed a systematic NMR and X-ray crystallographic study of the response 
of the HL structure towards pH variation in the range from pH 3-8, which is supported by other 
biophysical methods (SPR, AFM, Thioflavin T fluorescence assay) and in silico approaches. 
We also analyse the relation between (de)protonation of residue Glu35 and movements of the 
adjacent residue Trp109 as well as of surrounding helices. Due to the strong pH dependence 
of the structural properties of lysozymes these results have to be considered as essential 
prerequisites for a detailed affinity study of HL and HEWL interacting with the weakly binding 
di- and tetrasaccharids 1 and 2, the units of the glycan chain of the lipopolysaccharide (LPS) 
from K. pneumoniae. 
My part within this study was to perform the X-ray crystallography, Molecular modelling and 
data mining experiments and analyse the related results. 
 
2.2 The main experimental results 
1) Using SPR studies, we could show that the saccharide part of LPS determines the specific 
interactions with the lysozymes. For this reason we have focused our research on defined 
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building blocks of the LPS glycosidic chain and started with the disaccharide fragment of 
Klebsiella pneumoniae. 
2) Molecular modelling has shown that dimerization of human lysozyme monomers is very 
likely. However, we have found no evidence for these in silico results when human lysozyme 
was analyzed with NMR methods at different pH values. 
3) When comparing the X-ray structures of the human lysozyme from which we have grown 
crystals in the absence and in the presence of disaccharide 1 at different pH values we have 
found that a certain amino acid residue (i.e. Trp63) plays a crucial role in the carbohydrate 
interaction process. 
4) The analysis of protein-carbohydrate interactions in the Protein Data Bank (PDB) with 
GlyVicinity reveals that Trp (W), Tyr (Y), Asn (N) and Asp (D) are the most overrepresented 
amino acids in the vicinity of α-D-Galp residues. 
5) The differences in the patterns of the electrostatic surface potentials argue in favour of 
variations in ligand binding as well as deviations in the aggregation/ fibrillation behaviour when 
comparing the human with the avian lysozyme. 
6) The NMR studies suggested that mixtures of HL and the disaccharide building block 
(repeating unit) of the Klebsiella pneumoniae LPS (compound 1) yielded only at pH 5.5 
observable changes in the chemical shift values; at pH 3.8 no intermolecular interactions 
could be detected. Both helices and in particular also the catalytic residue Glu35 respond to 
the addition of compound 1. In addition, a change of chemical shift is also observed on the β-
domain in the center of the first  strand. Noteworthy is the strong reduction of line broadening 
for Hε1 of Trp109 in the presence of the sugar. 
7) In contrast to HL, intermolecular interactions of HEWL could be observed both at pH 3.8 
and 5.5. At the lower pH, chemical shift changes due to binding are wider spread than with HL, 
involving a larger number of residues and covering the length of the entire enzymatic cleft, i.e. 
all six subsites: Asn44 H, Asp52 H, Gln57 H, Asn59 HN and H, Lys97 and Asp101 H, Ala107 
and Ala110 HN. At lower pH, the β-domain is strongly affected by the presence of sugar. At 
the higher pH the binding is similar to that in HL, affecting Glu35 HN and H, Asn44 H, Trp108 
H1 and Hε1, Trp111 HN and Arg112 HN, i.e. only subsites D-F. 
8) The crystal structure of the HL-tetrasaccharide complex revealed carbohydrate chain 
packing close to the A, B, C and D binding sites of HL, which primarily occurred through 
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residue-specific, direct or water-mediated hydrogen bonds and hydrophobic contacts. Overall, 
these results support a crucial role of the Glu35/Asp53/Trp63/Asp102 residues in HL binding 
to the tetrasaccharide (compound 2). These observations suggest an unknown glycan-guided 
mechanism that underlies recognition of the bacterial cell wall by lysozyme and may 
complement the HL immune defense function. 
 
3. Research manuscript 
The detailed experimental methods, material, results as well as conclusion are presented in 
our following manuscript. 	
3.1  Lysozyme's lectin-like characteristics facilitates its immune defense function  
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Abstract  
Interactions between human lysozyme (HL) and the lipopolysaccharide (LPS) of Klebsiella pneumoniae 
O1, a causative agent of lung infection, were identified by surface plasmon resonance (SPR). To 
characterize the molecular mechanism of this interaction, HL binding to synthetic disaccharides and 
tetrasaccharides representing one and two repeating units, respectively, of the O-chain of this LPS were 
studied. pH-dependent structural rearrangements of HL after interaction with the disaccharide were 
observed through NMR. The crystal structure of the HL-tetrasaccharide complex revealed carbohydrate 
chain packing into the A, B, C and D binding sites of HL, which primarily occurred through residue-
specific, direct or water-mediated hydrogen bonds and hydrophobic contacts. Overall, these results 
support a crucial role of the Glu35/Asp53/Trp63/Asp102 residues in HL binding to the tetrasaccharide. 
These observations suggest an unknown glycan-guided mechanism that underlies recognition of the 
bacterial cell wall by lysozyme and may complement the HL immune defense function. 
 
Lower respiratory tract infections are among the top ten causes of death worldwide and are of particular 
relevance in chronic lung diseases. Lysozyme is one of the most abundant antimicrobial proteins in the 
airways and alveoli. The concentration of this enzyme in the surface liquid of the human airway is 
estimated to be 20–100 µg/ml, which is sufficient to kill important pulmonary pathogens such as Gram-
positive Staphylococcus aureus and Gram-negative Pseudomonas aeruginosa1. Klebsiella pneumoniae, 
which is a frequent cause of nosocomial infection and may be responsible for up to 20% of the 
respiratory infections in neonatal intensive care units2, is also specifically attacked by lysozyme3. 
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Human lysozyme (HL, also known as muramidase, N-acetyl muramide glycanohydrolase, or EC 
3.2.1.17; Figure 1A) is a 130-amino acid cationic protein that cleaves the glycosidic bonds of N-acetyl-
muramic acid (Figure 1B), thereby damaging the bacterial cell wall and ultimately killing bacteria by 
lysis in cooperation with defensins. An inter-domain cleft in HL contains six binding pockets (labeled 
A-F in Figure 1A), and a strictly conserved catalytic residue Glu35 is located between the D and E 
sites4. Co-crystallization of HL with N-acetyl-chitohexaose (GlcNAc)6 (Figure 1B) has revealed а 
crystal structure with non-covalently linked (GlcNAc)4 and (GlcNAc)2 in subsites A-D and E-F, 
respectively5. 
In addition to the well-known muramidase activity of HL, increasing evidence suggests the 
existence of non-enzymatic and/or nonlytic modes of action against Gram-negative and Gram-positive 
bacteria6, 7. Furthermore, lysozyme has antitumor8 and antiviral activities7, and it enhances the immune 
system9. The mechanisms of these activities remain unclear, and the dominant questions involve how 
HL recognizes pathogenic microbes. The ability of lysozyme to interact with lipopolysaccharides 
(LPSs) was demonstrated in the late 1980s10, 11. However, the details of this interaction (i.e., how 
binding specificity is established between specific parts of the lysozyme protein and the LPS 
carbohydrate units) have not been examined. The attraction between lysozyme and LPS has been 
largely attributed to non-specific hydrophobic interactions of lysozyme with lipid A, which is the 
innermost hydrophobic component of LPS and is primarily responsible for its toxicity. To examine 
whether lysozyme specifically interacts with bacterial LPS and particularly with the O-chains that form 
the outer layer of the bacterial cell wall, we performed SPR-based experiments as previously 
described12. In our SPR experiments, the LPS from bacterial K. pneumoniae O1 pathogens, which are 
involved in severe hospital-acquired infections (HAIs) and are clinically relevant to infections beyond 
those of the airways13, 14, were immobilized through hydrophobic interactions between the lipid A 
portion and the SPR sensor chip, and they were treated with HL (Figure S1 in Supplementary 
Information) to clearly demonstrate the interaction between HL and the immobilized LPSs. To assess 
whether the O-chains of these LPSs were involved in the observed interactions, we combined NMR, 
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molecular modeling, data mining and X-ray crystallography techniques to investigate HL binding to 
synthetic disaccharide 115 and tetrasaccharide 2 (Figure 1C), which represented one and two repeating 
units of the O-chain of K. pneumoniae O1, respectively, at the sub-molecular level. 
 
 
Figure 1. Lysozyme and its carbohydrate ligands A: Structure of HL (PDB code 1LZS5) with selected residues 
(Glu35, Asp53, and Trp109). Binding sites A-F are indicated by letters in green circles. Helices are colored as 
follows: a, violet; b, magenta; c, red; d, orange. In the orientation shown, the α-domain is to the right of the 
binding cleft and the β-domain is to the left. B: Hydrolysis of the (1→4)-glycosidic bond between N-acetyl 
muramic acid and N-acetyl glucosamine in the peptidoglycan. C: Structures of the repeating unit of the O-chain 
of the K. pneumoniae O1 lipopolysaccharide and the structurally related synthetic disaccharide 1 and 
tetrasaccharide 2. Monosaccharide units are numbered with Roman numerals. 
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RESULTS 
NMR observations of structural rearrangements of the binding site of HL 
The lysozyme enzymatic reaction requires an initial protonated form of the highly conserved Glu35, 
which exhibits a high pKa of 6.816. A pH-based NMR titration of lysozyme with the weakly binding 
disaccharide 1 was used to provide atomistic insights into the relationship between the (de)protonation 
of Glu35 and its associated structural rearrangements in the surrounding helices, which were suspected 
to control the continuation of the catalysis reaction and hence influence specificity. 
The pH dependence of the lysozyme binding site modulations was analyzed for free lysozyme and 
lysozyme in the presence of the weakly binding disaccharide 1 (Figure 1C), and conclusions regarding 
the interactions between lysozyme and disaccharide 1 were made on the basis of chemical shift changes. 
However, intermolecular NOEs between these two molecules were undetectable, thus suggesting the 
existence of only dynamic binding modes for which no stable structure could be determined. The results 
were therefore compared with the stable complex of lysozyme with tetrasaccharide 2 (Figure 1C), 
which occupies four binding sites (A, B, C and D) (Figure 1A). 
 
NMR-based investigation of free human lysozyme 
Titrations in the 3.8-8.5 pH range were observed for free HL by 1D and 2D NMR (Table S1, 
Supplementary Information). Figure 2A shows 1D spectra for different pH values, illustrating that the 
indole ring proton (Hε1) of residues Trp34, Trp109, Trp112, and the amide protons of Cys77 and 
Ala111 are strongly affected by pH. The most pronounced change was observed for Trp109, with a shift 
to lower field by 0.43 ppm, whereas Trp64 and the overlapping Trp28 (at 9.13 ppm, not shown) did not 
titrate in the 3.8-8.5 pH range. 2D NOESY spectra complemented the 1D titrations and provided a 
comprehensive picture of the chemical and structural changes in the enzyme (Figure 2B). Again, large 
changes were observed for the HN of Ala111 (around pH 6.8) and for various side-chain atoms of 
Trp109. Additional chemical shift perturbations were also observed in large portions of helices b and d 
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(Figure 1A). The observed effects outside of these two helices included Gln58, Ile59, Val100 and 
Ala108 (Table S1, Supplementary Information).  
The strongest shift changes in the spatial neighborhood of the catalytic residue Glu35 were revealed 
by mapping of these shift changes onto the 3D structure of HL; they affect most of the b and d helices, 
and the loop between the second and third β-strands from the β-domain (Figure 2C). Changes involving 
the HNs of residues Gln58, Ile59, Val100 and Ala108, were located in the plane of the Trp109 ring, 
thus indicating rotation of this ring. The common pKa value (within the measurement error) of all these 
resonances, about pH 6.8, coincided with the reported (and unusually high) pKa value of the catalytic 
Glu35 protonation site16, and furthermore identical pKa strongly indicated that all of these events are 
coupled (Table S1, Supplementary Information). The large shift variation of ~0.84 ppm for the HN of 
Ala111 is probably the result of an adjacent charge change, and the obvious cause of this shift variation 
is the Glu35 side chain, whose carboxyl group is nearby at 3.4 Å17. The remarkable behavior of the HN 
of Ala111 was an important observation that demonstrated a direct coupling between helices b and d. 
The next largest shift changes concerned the Trp109 side chain, which is an important component of the 
binding site surface and exhibited direct interactions with Glu35; the shortest distance between these 
side chains is 2.2 Å. 
In addition to the well-known relative motions of the two domains required for ligand binding, 
human lysozyme undergoes a series of specific processes, both chemical and structural, when the pH is 
varied near 6.8. These processes include large parts of the α-domain with the catalytic Glu35, the side 
chain of Trp109, most of the b and d helices, and the loop between the second and third β-strands from 
the β-domain (Figure 2C). The identical pKa (within the measurement error) of all relevant resonances 
strongly indicated that all of these events are coupled (Table S1, Supplementary Information). Although 
some strong interactions with Glu35 have been previously reported (e.g., with Trp10916) or can be 
assumed on the basis of their proximities (e.g., to the amide of Ala 111), other titrating residues 
appeared to be too far away from Glu35 to show direct effects due to the charge change upon 
(de)protonation; reports have instead focused on a higher flexibility of the α-domain that involves 
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mutual rearrangements between helices b and d, which mirrors similar observations regarding factors 
such as ligand binding, temperature or pressure variations18, 19. The relative position of helices b and d 
within the α-domain modulated by the hydrogen bonding network with Glu35, Trp109 and Ala111 is 
further defined by the previously described interaction between Arg115 and Trp34, and the Arg115Glu 
mutation has been reported to modify both the position of helix d and the enzyme activity17. Thus, 
(de)protonation of Glu35 appears to trigger processes that spread over most of the α-domain. 
 
 
Figure 2. NMR-based investigation of free human lysozyme A: 1D spectra of pure HL at various pH values 
(indicated on the left border). For clarity, we show the residues, indole ring proton of Trp (Trp109, Trp112, and 
Trp34) and the HN of Cys77 and Ala111 (shown in top two traces), which show strong chemical shift 
perturbation. B: Selected 2D NOESY regions for HL at various pH values. Spectra for the different pH values are 
colored as follows: 3.8, red; 5.0, light blue; 5.5, green; 6.8, orange; 7.4, black; 7.7, purple; 8.1, dark blue. 
Chemical shifts that varied with pH are indicated by arrows on or beside the corresponding peaks with different 
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colors. Peak contours are calibrated such that the intensities of the HN-HN cross-peaks for helix c are constant 
across all pH values. C: Epitope mapping of HL from the pH titration. Spheres are color-coded as follows: atoms 
on helix b are magenta, atoms on helix d are orange, and Trp109 side-chain atoms are blue. Additionally, black 
spheres mark the HN positions from the following residues: 58 and 59 (near D53), 100 (at the end of the red helix 
c), and HN 108 (before Trp109). The structure is rotated by 30° around a vertical axis with respect to Figure 1A; 
the helix coloring is the same, and helix a is presented as a thin violet curve for clarity. 
 
Interaction between human lysozyme and disaccharide 1, observed by NMR 
The binding sites of the c-type lysozyme include six individual subsites (labeled A-F, Figure 1A) for 
specific interactions with multiple saccharide rings4. Mixtures of HL and disaccharide 1 (Figure 1C) 
yield observable chemical shift value changes at only pH 5.5; effects caused by intermolecular 
interactions were undetectable at pH 3.8. At pH 5.5, the nuclei in the residues surrounding the D-F sub-
sites that show changes were Glu35 HN and Hγ, Asn44 H, Trp109 Hδ1 and Hε1, and Arg113 HN 
(Figure 3A).  
The affected residues were mapped onto the 3D structure of HL in Figure 3B and demonstrated 
transient binding at subsites D and E (Figure 1A). Helices b and d and the catalytic Glu35 in particular 
responded to the addition of disaccharide 1. Furthermore, a chemical shift change was observed on the 
β-domain in the center of the first strand (Asn44). Since Trp109 is part of the binding cleft (Figure 1A), 
it is unsurprising that the aforementioned structural changes mediated by this tryptophan were affected 
by ligand binding. The observations of chemical shift changes for Arg113, whose location was distal to 
all binding sites and buried behind the preceding helix loop (residues 110-111), were in agreement with 
a coupling between the ligand-binding and conformational effects. 
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Figure 3. Interaction between human lysozyme and disaccharide 1, observed by NMR. A: Selected 
regions from the 2D NOESY spectra of pure human lysozyme (red) and a 1:1 mixture with disaccharide 
1 (black) demonstrate some of the shift changes observed after the addition of disaccharide 1. Peak 
labeling is as described in Figure 2B. B: Mapping of resonances with chemical shift changes after the 
addition of disaccharide 1 onto the 3D structure of lysozyme; the atoms are indicated as green spheres. 
The structure has an identical orientation and helix coloring to that described in Figure 1A. 
 
Molecular modeling of the interaction between human lysozyme and disaccharide 1  
Molecular modeling20, 21 and data mining22, 23 tools are necessary for general discussions of the 
principles of carbohydrate-protein interactions. In order to gain some kind of insight into the binding 
mode for disaccharide, molecular modelling is a rational tool to use. During the docking, each 
simulation includes 100 runs which generate 100 conformers for the ligand. The top 10 conformers with 
low energy was selected for further analysis. For this step, both energy and ligand binding were 
considered. In fact, in the end, only the conformer with the lowest energy was selected for interaction 
description, which also shows a rational binding conformation. Figure 4A displays the most favorable 
energetic structure of HL and disaccharide 1. A close-up view of the basic pocket with the LPS-
interacting side chains is presented in Figure 4B. Red dashed lines indicate the hydrogen bonds. The 
simulation  of the binding for disaccharide indicated binding near the substrate binding sites C and D. 
This observation is in agreement with the analysis based on the crystal structure of HL with the 
tetrasaccharide since the binding sites C and especially D provided most of the interactions between 
sugar and protein. Comparisons of this specific result with similar cases in the Protein Data Bank (PDB) 
uncovered numerous meaningful agreements. The protein-carbohydrate interaction analysis in the PDB 
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revealed that Trp, Tyr, Asp, Asn and His were the most overrepresented amino acids in the vicinity of 
α-D-Galp residues (Figure 4C). The previously described data mining approach23, 24 provided important 
information regarding the amino acid residues that typically occur in the vicinity of α-D-Galp. Using 
our data mining protocols, we performed an overview of the molecular interactions between α-D-Galp 
and the functional groups of certain amino acid residues (Figure 4C) in relation to the general structural 
aspects of lysozyme-carbohydrate interactions. 
Molecular modeling calculations with respect to the electrostatic surface potentials and 
hydrophobic patches were also performed (Figure S2). The differences in the patterns of the 
electrostatic surface potentials suggest variations in ligand binding and deviations in the 
aggregation/fibrillation behavior between human and avian lysozyme. 
 
 
Figure 4. Molecular modeling of the interaction between human lysozyme and disaccharide 1. A: Molecular 
surface of lysozyme with carbons (green), oxygens (red), nitrogens (blue) and hydrogens (gray). B: Close-up 
view of the basic pocket with disaccharide 1 shown in stick rendering and with hydrogen bonds indicated by red 
dashed lines. C: Amino acid residues in the vicinity of α-Gal in the protein-carbohydrate complexes deposited in 
the Protein Data Bank (PDB), which indicates the deviation from natural abundance. Trp, Tyr, Asp, and His are 
overrepresented by greater than 100% (i.e., they are observed twice as often or more in a 4 Å radius of α-Gal 
compared with an average protein). 
 
X-ray crystallography-based study of the interaction between HL and disaccharide 1  
To provide data that are independent of the results of the NMR measurements and molecular modeling 
calculations, X-ray crystallographic experiments were performed for human lysozyme. Extensive 
experiments to co-crystallize HL with bound disaccharide 1 (Figure 1C) at different pH values failed. 
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We did not observe a convincing electron density for bound disaccharide, even after the crystals were 
soaked with high disaccharide concentrations. We assume that the disaccharide was too short to provide 
sufficient interaction opportunities with the protein to form a stable complex. Therefore, the study of a 
longer oligosaccharide ligand representing a larger polysaccharide fragment was initiated.  
 
Overall structure of the HL-tetrasaccharide 2 complex 
The crystal complex of HL with tetrasaccharide 2 was successfully obtained by co-crystallization of 1.9 
mM HL in the presence of 20 mM tetrasaccharide 2. The X-ray diffraction resolution of the crystals was 
approximately 1.0 Å. A summary of the data collection and structure refinement is presented in Table 1. 
For details regarding the definitions of the individual parameters, see Table S2 in the Supplementary 
Information.  
 
Binding sites in the HL-tetrasaccharide 2 complex 
The refined structure of human lysozyme in complex with tetrasaccharide 2 reveals the binding of 
tetrasaccharide 2 near the A, B, C, and D substrate-binding sites of the enzyme (Figure 5). The Galf–I 
furanoside unit of tetrasaccharide 2 is located near site A, and the Galp-II pyranoside unit is located 
near site B. The second repeating unit (Galf-III)-(Galp-IV) is in proximity to sites C and D. Both Galp 
units of tetrasaccharide 2 adopt a chair conformation. Overall, there are eight direct hydrogen bonds 
between tetrasaccharide 2 and the amino acid residues of HL. Seven residues (Ile59, Asn60, Tyr63, 
Trp64, Ala76, Asp102, and Trp109) form hydrophobic interactions. Through comparison with tetra N-
acetyl-D-glucosamine, it is clear that the sugar ring systems of tetrasaccharide 2 are not identically 
positioned. However, a similar number of direct hydrogen bonds, hydrophobic interactions and water-
mediated bridged hydrogen bonds jointly contribute to the overall binding affinity. 
A major contribution to the overall binding affinity for tetrasaccharide 2 is provided by bridged 
hydrogen bonds that are mediated by approximately 20 water molecules within the binding pocket 
toward the following lysozyme residues: Glu35, Asp49, Asp53, Asn60, Tyr63, Val99, Arg98, Gly105, 
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Ala108, Val110, and Ala111 (Figure 6 and Table S3, Supplementary Information). This ratio and mix 
of interactions is similar to those observed for (GlcNAc)4 (PDB entry 1LZR) and (GlcNAc)4/(GlcNAc)2 
(PDB entry 1LZS)5 bound to HL. The superposition of HL-2 with HL-(GlcNAc)4 and with HL-
(GlcNAc)4/(GlcNAc)2 resulted in RMSD values of 0.23 Å and 0.46 Å, respectively (based on 130 C-
alpha positions), thus indicating that the three-dimensional structures of the protein-ligand complexes 
are similar in all three complexes. 
The binding modes of tetrasaccharides 2 and (GlcNAc)4 in the A, B, C, and D sites display small 
but significant differences. Specifically, Arg98 forms a direct hydrogen bond between its side-chain 
atom, Nε2, and the O1 atom of the Galf-I unit in site A of the HL-2 complex. Additionally, water 
molecules mediate a bridged hydrogen bond between the NH group of Arg98 and the OH group of 
Galf-I. Arg98 is not involved in the binding of (GlcNAc)4 or (GlcNAc)2 to HL. 
 
 
Figure 5. Molecular surface of HL in the complex with tetrasaccharide 2. A: Representation of the molecular 
surface of HL is colored according to the electrostatic potential. Tetrasaccharide 2 is represented by sticks for one 
conformation (carbon atoms in cyan and oxygen atoms in red) and by black lines for an alternative conformation. 
The HL (PDB-entry 1LZR5)-bound chitotetraose (GlcNAc)4 ligand is superimposed and represented by sticks 
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(carbon atoms in yellow). B: Close-up view of the superimposed ligands, tetrasaccharide 2 (carbon atoms in 
cyan) and (GlcNAc)4 (carbon atoms in yellow, oxygen atoms in red and nitrogen atoms in blue. C: 
Representation in stereo of the electron density 2Fobs-1Fcalc omit map defining bound tetrasaccharide 2. The Galp-
II, Galf-III and Galp-IV units are represented by sticks (carbon atoms in cyan and oxygen atoms in red). The 
protein backbone is indicated by a ribbon representation in green. The representation was generated using 
PyMOL v.1.627. 
 
The major interactions of the Galp-II unit in site B of HL are managed by direct hydrogen bonds 
with the surrounding amino acid residues Tyr63, Asp102, and Gln104. In addition to the hydrogen bond 
between atom O7 and the OH group of Tyr63, the aromatic plane of Tyr63 provides a strong 
hydrophobic interaction with the Galp-II moiety. A similar interaction of Tyr63 with the second 
GlcNAc residue is present within the HL-(GlcNAc)4 complex. Notably, the orientation of the Tyr63 
side chain in the HL-2 complex is rotated by ca. 10° for an optimal interaction with the shifted sugar 
position in comparison with the GlcNAc unit. The Oδ2 side-chain atom of the Asp102 residue 
contributes two hydrogen bonds to the binding of the first two sugar units of 2, but only one direct 
hydrogen bond to the first GlcNAc unit is observed in (GlcNAc)4. In the HL-(GlcNAc)4/(GlcNAc)2 
complex, atom Oδ1 forms two hydrogen bonds with atoms N and O6 of the first GlcNAc moiety of 
(GlcNAc)4/(GlcNAc)2. As a consequence of these differences, tetrasaccharide 2 adopts a closer binding 
orientation toward the ‘bottom’ of the binding pocket, as compared with (GlcNAc)4 and 
(GlcNAc)4/(GlcNAc)2.  
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Figure 6. Binding site of human lysozyme with bound tetrasaccharide 2. The ligand is shown as a ball-and-stick 
representation; the bonds are indicated in purple. The protein residues are represented without side chains. 
Hydrogen bonds are shown as black dashed lines, and the spoked arcs represent protein residues that form 
hydrophobic interactions with the ligand. The cyan spheres indicate water molecules, which provide bridged 
hydrogen bonds between the ligand atoms and amino acid residues. The individual interactions are provided in 
Table S3 of the Supplementary Information. The representation was derived from an analysis with LigPlot+28. 
 
The Galf-III unit is located near the C substrate-binding site. Two hydrogen bonds are formed: one 
occurs between the Trp64 atom Nε1 and atom O19, and the other occurs between atom O15 and the 
main-chain atom N of Asn60. Similar hydrogen bonds are contributed by these two residues for sugar 
binding in the HL complex to produce HL-(GlcNAc)4 and HL-(GlcNAc)4/(GlcNAc)2. The unit Galp-IV 
is located between the two substrate-binding sites, C and D. The only two direct hydrogen bonds are 
formed between atom O16 and the main-chain atom O of Gln58 and between atom O15 and the main-
chain atom N of Asn60. Within the HL-(GlcNAc)4 complex, a similar hydrogen bond is contributed by 
 	 23	
Gln58 to the fourth GlcNAc moiety. Additionally, two residues, Asn46 and Asp53, form direct 
hydrogen bonds with GlcNAc atom O1 in the HL-(GlcNAc)4 complex. Interestingly, in the HL-
(GlcNAc)4/(GlcNAc)2 complex, Gln58 is not involved in the interaction with the fourth GlcNAc 
moiety; instead, it is involved in the interaction with the Asn46 side chain and the main-chain atoms of 
Ala108 and Val110. Notably, approximately 10 water molecules play an important role in mediating 
interactions between unit Galp-IV of tetrasaccharide 2 and the Glu35, Asp49, Ser51, Asp53, Gln58, 
Gln104, Ala108, and Ala111 residues near the D and E substrate-binding sites. It is possible that a fifth 
sugar moiety may be adopted within this interaction network, which would contribute to a further gain 
in binding affinity. 
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Table 1. Data collection and refinement statistics. PDB	entry	 5LSH	Data	collection	 	Temperature	(K)	 100	Resolution	range	(Å)	a	 29.05-1.061	(1.099-1.061)	Space	group	 P	2(1)2(1)2(1)	Unit	cell	a,	b,	c	(Å)	 33.1,	56.0,	60.5	Multiplicity	a	 11.9	(9.8)	Completeness	(%)	a	 92	(69)	Mean	(I)/σ(I)	a	 17.06	(1.52)	Rp.i.m.	(%)	a,	b	 7.6	(108.8)	CC(1/2)	(%)	a,	b	 100	(63.3)	Refinement	 	R-work	(%)	a,	b	 18.1	(32.4)	R-free	(%)	a,	b	 20.4	(33.6)	
B-factors	(Å2)	(No.	of	non-hydrogen	atoms)	 	All	 11.4	(1414)	Ligand	KTS	 16.6	(90)	Water	molecules	 20.9	(160)	rmsd	(bonds)	(Å)	 0.013	rmsd	(angle)	(°)	 1.58	Rotamer	outliers	(%)	 1.7	Ramachandran	plot	statistics	(%)	 	Favored	 97.0	Allowed	 2.8	Outliers	 0.0	
 
a Values in parentheses are for the high-resolution shell. 
b For details regarding the definitions of the individual parameters, see Table S2 in the 
Supplementary Information. 
 
DISCUSSION 
This study is the first to indicate that tetrasaccharide 2, which represents part of the O-chain of the 
K. pneumoniae O1 LPS, binds to HL at its conserved sites (A, B, C and D) within the substrate binding 
pocket; this binding occurs mainly through direct hydrogen bonds and indirect hydrogen bonds that are 
mediated by water molecules. Our titrations provide a detailed picture of how the active site and the 
overall structure are related to each other. At pH 6.8, deprotonation of Glu35 occurs, which inactivates 
the enzyme at this unusually high pKa value, and helices b (with Glu35) and d undergo a substantial 
repositioning. Because one of the first catalysis steps also involves the deprotonation of Glu35, these 
domain-wide structural changes are likely to modulate the continuation of the catalysis reaction. 
Together with earlier studies18, 19, our study indicates a general flexibility and lower stability of helix d, 
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which can be affected by numerous factors, including sugar binding and temperature changes. The 
ability of lysozyme to exhibit complex responses to environmental changes is evidenced by the 
following observations: the titration effects observed for the proton probes on Glu35, Trp109 and 
Ala111; the line broadening of local motions that involve Trp109 and Ala111; the spatial neighborhood 
of these three residues, which allows for direct interactions; and the wide range of titrating resonances 
on helices b and d. These structural rearrangements appear to be strongly coupled to enzyme activation 
by the (de)protonation of Glu35. 
The carbohydrate binding site of HL displays a strong structural plasticity. Only a few amino acid 
residues are in direct hydrogen-bonding contact with the oligosaccharide chain. Most interactions are 
formed by hydrophobic contacts and particularly by water-mediated bridged hydrogen bonds. These 
latter two modes of interaction are less constraining and can be used to adopt binding environments for 
various ligands. The lectin-like ability of HL to interact with the O-chain of bacterial LPS highlights the 
strong possibility of a new role of HL in immune defense functions. This study may enable future 
developments of new and important therapeutic approaches to prevent and treat bacterial infections. 
 
METHODS 
Methods and any associated references are available in the online version of the paper. 
 
Accession codes. Coordinates for of human lysozyme in complex with tetrasaccharide 2 representing 
two repeating units of the O-chain of K. pneumoniae have been deposited in the Protein Data Bank 
under accession code PDB 5LSH. 
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ONLINE	METHODS		
Lysozyme. Recombinant HL was provided by T. E. Weaver. The HL was purified as previously 
described for other lysozymes3, 25. 
 
Oligosaccharides. The synthesis of disaccharide 1 was performed15 using the recently discovered 
pyranoside-into-furanoside rearrangement15, 26. The synthesis of tetrasaccharide 2 was based on similar 
approaches and is described in the supplementary information (Scheme S1). 
 
SPR analysis was performed on a protein interaction array system (ProteOn XPR36, Bio-Rad, Munich, 
Germany). LPS from Klebsiella pneumoniae O1 (SIGMA) was immobilized onto flow cells of a GLM 
sensor chip (25 µg in 250 µL Protein acetate buffer, flow rate 30 µL/min until saturation). Lysozyme 
has been diluted 1:4 in buffer, final volume 250 µL) and injected at a flow rate 30 µL/min over flow 
cells coated with LPS. Analyses included an association step (lysozyme injection) of 350 sec (B350), 
followed by a dissociation step (only buffer) for 700 seconds (B700). A regeneration of the sensor 
surface was performed before each testing by injecting 25 mmol/L sodium hydroxide solution (100 
µL/min for 18 sec). Data were analysed with the computer software (ProteOn manager software, Bio-
Rad). A B700/B350 ratio was used to differentiate the LPS-to-lysozyme binding processes. Data were 
analysed with computer (ProteOn manager software, Bio-Rad). 
 
NMR sample preparation. All samples were prepared by dissolving lyophilized human lysozyme 
(HL) in 0.3 ml H2O containing 20 mM sodium phosphate buffer and 10% D2O. Final concentrations of 
all samples were 0.5 mM protein as determined by measurement of the molar extinction coefficient, 
using E1%= 25.5 for HL. For mixtures of lysozyme with disaccharide1, a 40mM stock solution was 
prepared. The following samples were prepared: pure HL as well as 1:1 mixtures of these proteins with 
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disaccharide1  at pH 3.8 and 5.5. Additional samples for HL were prepared in a similar manner for the 
pH titrations described below. 
 
NMR measurements. All NMR spectra were recorded on a Varian Unity INOVA 800 MHz 
spectrometer at 35 oC using 3 mm Shigemi tubes. The 1H chemical shifts were referenced to DSS. For 
disaccharide-lysozyme interaction measurements, equivalent amounts of disaccharide1 were added to 
the enzymes. Homonuclear 2D NOESY (mixing time 150 ms) and TOCSY (mixing time 50 ms) with 
spectral width 11204 Hz for both dimensions were acquired with 512 increments in the indirect 
dimension and 4096 data points in the direct dimension, using Watergate solvent suppression and a 
pulse sequence repetition delay of 1.5 s. All data were processed with the NMRPipe software package29 
by zero–filling to 1024 points in the indirect dimension and ending with either a Gaussian or a shifted 
sine-bell function. After zero-filling the digital resolution was 0.0015 ppm for the direct dimension and 
0.014 ppm for the indirect dimension. For pKa determinations of HL, ten NOESY spectra were 
recorded in the pH range 3.8-8.1 (3.8, 4.2, 4.6, 5.0, 5.5, 6.2, 6.8, 7.4, 7.7 and 8.1). A separate sample of 
HL was prepared for recording of 22 1D spectra covering the pH range of 3.17-8.13 in steps of ~0.2 
units. All 1D data sets were defined by 4096 complex points and consisted of 256 transients. The digital 
resolution of the 1D spectra was 0.0024 ppm after zero-filling. Xeasy30, Mnova31, and CCPNmr32 were 
used for analysis and resonance assignment. Line widths are defined as half-width at half-height of a 
peak; for most peaks the line width was estimated to be 0.01 ppm. 
All pH adjustments were made by addition of small aliquots of either H3PO4 or NaOH. The pH 
meter was calibrated with standard solutions (from Sigma) at pH 4 and 7. The temperature dependence 
of the pH reading for HL was checked by recalibrating the pH meter at 35 °C: the difference between an 
incubated lysozyme sample at 35 °C and at room temperature was less than 0.1 pH unit. The pH for 
each sample was measured before and after each experiment to warrant constant conditions.  
 
Signal assignments. 1H resonance assignments at pH 3.8 and pH 5.5, both at 35 °C, were obtained for 
human lysozyme (HL) by transferring chemical shifts from the Biological Magnetic Resonance Bank 
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(BMRB, http://www.bmrb.wisc.edu/)33 entries 5130 and 1093, respectively, to the NOESY and TOCSY 
spectra. Based on chemical shift changes, conclusions about interactions between lysozymes and 
disaccharide 1 could be made in several cases as described in the main text. However, no intermolecular 
NOEs were detectable, suggesting dynamic binding modes only. 
 
Molecular modeling and data mining. Docking studies were performed with the AutoDock 4.2 software, 
which uses the Lamarckian Genetic Algorithm (LGA) implemented therein. For the docking of the LPS 
disaccharide fragment 1 with human or chicken lysozyme, the required file for the ligand was created 
by combining the Gaussian and AutoDock 4.2 software packages. The grid size was set to 126, 126, and 
126 Å along the X-, Y-, and Z-axis, in order to recognize the LPS glycan binding site of human or 
chicken, the blind docking simulation was adopted. The docking parameters used were the following: 
LGA population size = 150; maximum number of energy evaluations = 250000. The lowest binding 
energy conformer was taken from 10 different conformations for each docking simulation and the 
resultant minimum energy conformation was applied for further analysis. The MOLMOL34 and 
PyMOL27 software packages were applied for visualisation and analysis of the docked complex. Data 
mining of protein-carbohydrate interactions in the PDB was performed with GlyVicinity at a 
redundancy level of 70% (www.glycosciences.de/tools/glyvicinity/). Only non-covalently bound 
ligands in structures with a resolution of at least 3Å have been considered. The analysed dataset 
comprised 498 amino acids that have been found within a 4Å radius of 73 alpha-galactose residues in 
73 different PDB entries. 
 
X-ray. For crystallization, the hanging-drop vapor-diffusion method was performed in 24-well plates. 
Single crystals of the human lysozyme were obtained by mixture of 2 µl of the reservoir solution (0.8 M 
NaCl, 25 mM NaOAc, pH 4.4-5.6) with 2 µl of the protein solution (50 mg/ml in 100 mM NaCl, 10 
mM phosphate buffer, pH 6.0). These drops were equilibrated against 1 ml of the reservoir solution at 
291 K. For co-crystallization, the protein solution was mixed with a 10-fold excess of tetrasaccharide 2 
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and incubated for 30 min at room temperature prior to setting up the crystallization drop. Data 
collection for X-ray diffraction was performed at 100 K. The crystals were transferred into liquid 
nitrogen for flash-cooling without the prior addition of cryoprotectants. All data processing was 
performed using the XDS/XSCALE35 program package. Molecular replacement was carried out using 
the MOLREP36 program with the human lysozyme structure (PDB id: 1REX)37 as the search model. 
Model building and refinement were performed with the Refmac5 program as implemented in the CCP4 
suite38, 39 and PHENIX40. The COOT41 graphics program was used to interpret the electron density maps 
and to rebuild the structure. 
 
29. Delaglio, F., et al. NMRPipe: a multidimensional spectral processing system based on UNIX 
pipes. J. Biomol. NMR 6, 277-293 (1995). 30.	 Bartels,	 C.,	 Xia,	 T.H.,	 Billeter,	 M.,	 Guntert,	 P.	 &	 Wuthrich,	 K.	 The	 program	 XEASY	 for	computer-supported	NMR	spectral	analysis	of	biological	macromolecules.	J. Biomol. NMR 
6,	1-10	(1995).	31.	 Claridge,	T.	MNova:	NMR	data	processing,	analysis,	and	prediction	software.	J. Chem. Inf. 
Model 49,	1136-1137	(2009).	32.	 Vranken,	 W.F., et al.	 The	 CCPN	 data	 model	 for	 NMR	 spectroscopy:	 development	 of	 a	software	pipeline.	Proteins 59,	687-696	(2005).	33.	 Ulrich,	E.L., et al.	BioMagResBank.	Nucleic Acids Res. 36,	D402-408	(2008).	34.	 Koradi,	 R.,	 Billeter,	 M.	 &	 Wuthrich,	 K.	 MOLMOL:	 a	 program	 for	 display	 and	 analysis	 of	macromolecular	structures.	J. Mol. Graph. 14,	51-55,	29-32	(1996).	35.	 Kabsch,	 W.	 Integration,	 scaling,	 space-group	 assignment	 and	 post-refinement.	 Acta	
Crystallogr.	Sect.	D	66,	133-144	(2010).	36.	 Vagin,	 A.	&	Teplyakov,	 A.	MOLREP:	 an	 automated	 program	 for	molecular	 replacement.	 J	
Appl.	Crystallogr.	30,	1022-1025	(1997).	37	 Muraki,	M.,	Harata,	K.,	Sugita,	N.	&	Sato,	K.	Origin	of	carbohydrate	recognition	specificity	of	human	lysozyme	revealed	by	affinity	labeling.	Biochemistry	35,	13562-13567	(1996).	
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     ka (M-1 s-1) = 2.16 ×102 
kd (s-1) = 8.86 ×10-2 
  KD (M) = 3.98 × 10-4 
 
Figure S1. SPR data of human lysozyme interacting with LPS from K. pneumoniaeO1.  Five channels 
(A1 - A5) are used with different concentrations of LPS. Channel six was used for the running buffer 
only. The K. pneumoniae LPS concentrations are as follows: A1: 100 µl, A2: 80 µl, A3: 40 µl, A4: 20 
µl, A5: 10 µl (ka - association constant, kd – dissociation constants). 
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Scheme S1. The synthesis of disaccharide 11 was performed with the use of described1 synthetic block 3 
(scheme 1) which was prepared with the use of recently discovered pyranoside-into-furanoside 
rearrangement1, 2. Thus, the benzoylation of 3 (→4) and subsequent O-debenzylation, reduction of allyl 
group and 4’,6’-O-benzylidenation produced diol 5. On the other hand, removal of allyl-aglycon in 3 
and further introduction of imidate group gave the glycosyl donor 6. TMSOTf promoted coupling of 
disaccharide derivatives 5 and 6 proceeded with regioselective (1 → 3)-bond formation to give 
tetrasaccharide product 7. Its deblocking afforded to the desire tetrasaccharide 2. Its structure, and 
particularly β-(1→3)-structure of newly formed bond was determined on the basis of characteristic3 
values of JH1”,H2” coupling constant (<2.0 Hz) in 1H NMR spectrum and characteristic low-field 
chemical shift of C3’ (77.52 ppm) in 13C NMR spectrum.  Reagents and conditions: i. BzCl, Py, rt, 
90%; ii. 1) H2, Pd/C, EtOAc, rt, 2) PhCH(OMe)2, CSA, CH3CN, rt, 70% (2 steps); iii. 1) PdCl2, MeOH, 
rt, 2) CCl3CN, DBU, CH2Cl2, -30 oC, 59% (2 steps); iv. TMSOTf, CH2Cl2, -40 oC, 68%; v. 1) H2, 
Pd(OH)2/C, EtOAc-MeOH, rt, 2) NaOH, MeOH-H2O, rt, 85% (2 steps). 
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Table S1. Titrating resonances in HL upon pH variation in the range 3.8-8.5. 
Residue Atom Shift change Comment  
Titrations with pKa 6.8 near Glu 35 and/or on helices b or d 
Leu31 HN 0.09 helix b  
Leu31 Hβ 0.13 helix b  
Leu31 Hγ 0.12 helix b  
Lys33 HN 0.10 helix b  
Glu35 HN 0.17 catalytic residue  
Glu35 Hβ 0.21 catalytic residue  
Glu35 Hβ’ 0.14 catalytic residue  
Glu35 Hγ 0.08 catalytic residue  
Ser36 HN 0.13 helix b  
Tyr38 HN 0.08 helix b  
Gln58 HN 0.08 on β-domain, in Trp 109 plane  
Ile59 HN 0.12 on β-domain, in Trp 109 plane 
Val100 HN 0.10 in Trp 109 plane  
Ala108 HN 0.07 in Trp 109 plane  
Trp109 Hβ 0.32 Trp side chain in binding cleft  
Trp109 H1 0.28 Trp side chain in binding cleft  
Trp109 Hε1 0.48 Trp side chain in binding cleft  
Val110 HN 0.12 helix d, shift change also at pH 3.8  
Ala111 HN 0.84 helix d  
Trp112 Hε1 0.13 helix d  
Arg113 HN 0.21 helix d  
Asn114 HN 0.13 helix d  
Arg115 HN 0.11 helix d, interacts with helix b 
Other titrations  
Leu79 HN 0.08 pKa 7.1  
Asn75 Hδ 0.08 pKa 7.1  
Trp34 Hε1 - pKa >7.5  
Asn39 Hα - pKa >7.5  
Thr40 HN - pKa >7.5  
Gly127 HN - pKa >7.5  
Asp91 HN -  pKa <4.0  
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Figure S2. Electrostatic surface potentials for 15 c-type lysozyme. Electrostatic potentials where 
calculated with MOLMOL using charged Asp, Glu, Arg, Lys and uncharged His residues; the surfaces 
represent the centre positions of a solvent molecule rolling on the protein atoms. Below every figure, 
the PDB code is given. The different lysozymes are: 1dkk, bobwhite quail; 1ghl, pheasant egg white, 
1hhl, guinea fowl; 1jse, turkey; 1jsf, human; 1lmn, rainbow trout; 1qqy, canine milk; 2gv0, soft shell 
turtle; 2ihl, Japanese quail egg white; 2vb1, hen egg white; 2z2f, bovine stomach; 2eql, equine milk; 
1gd6, bombyx mori; 1iiz, tasar silkworm; 2fbd, musca domestica. 
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Table S2. Data collection and refinement statistics. 
 
PDB entry 5LSH	
Data collection 	
Synchrotron X-ray source PETRAIII (DESY) 
Detector Pilatus 
Wave length (Å) 0.9762 
Temperature (K) 100 
Resolution range (Å) 29.05  - 1.061 (1.099  - 1.061) 
Space group P 2(1)2(1)2(1) 
Unit cell a, b, c (Å) 33.1, 56.0, 60.5 
Total reflections a 567827 (34483) 
Unique reflections a 47721 (3498) 
Multiplicity a 11.9 (9.8) 
Completeness (%) a 92 (69) 
Mean(I)/σ(I) a 17.06 (1.52) 
Rp.i.m.(%) a, b 7.6 (108.8) 
CC(1/2) (%) a, c 100 (63.3) 
CC* (%) a, c 100 (88.0) 
Wilson B-factor (Å2) 9.80 
Refinement 	
Reflections used in refinement 47429 (3498) 
Reflections used for R-free 2372 (175) 
R-work (%) d 18.1 (32.4) 
R-free (%) e 20.4 (33.6) 
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CC-work(%) a, c 96.9 (69.4) 
CC-free (%) a, c 95.2 (70.1) 
B-factors (Å2) (No. of nonhydrogen 
atoms) 
	
All 11.4 (1414) 
Main chain 9.3 
Side chain 11.4 
Sodium ion 17.3 (1) 
Chlorid ion 13.2 (3) 
Ligand KTS 16.6 (90) 
Water molecules 20.9 (160) 
Estimated coordinate error (Å) f 0.007 
rmsd (bonds) (Å) 0.013 
rmsd (angle) (°) 1.58 
Molprobity all-atom clashscore 7,47 
Rotamer outliers (%) 1.7 
Ramachandran plot statistics (%) 	
Favoured 97.0 
Allowed 2.8 
Outliers 0.0 
 
a Values	in	parentheses	are	for	the	high-resolution	bin. 
b  
	 where Ii(hkl) is the intensity of the ith individual measurement of the reflection with Miller 
indices hkl and <Ii(hkl)> is the mean intensity of all measurements of I(hkl), calculated for I ≥ 
3σ(I); N is the redundancy or multiplicity of the observed reflection4,5. 
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c CC(1/2), percentage of correlation between intensities from random half datasets. Correlation 
significant at the 0.1 % level. CC*, the CC of the full dataset against the true intensities6. 
d  
	 where	Fobs	and	Fcalc	are	the	observed	and	calculated	structure-factor	amplitudes,	respectively. 
e Rfree is equivalent to Rcryst but calculated with reflections (5 %) omitted from the refinement 
process7, 8. 
f Calculated based on a Luzzati plot using the program SFCHECK9. 
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Table S3. Interactions of tetrasaccharide 2 (KTS) within the binding cleft of human lysozyme. 
Residue-Atom	
Atom	
(KTS)	 Ring	
Distance	
(Å)	 Type	of	bond	
D-Galf-I	 	 	 	 	Ala76-CB	 C	 1	 3.8	 Hydrophobic	Arg98-NH2	 O1	 1	 3.1	 Hydrogen	Bond	Arg98-NH2:HOH-O	 O	 1	 2.9	 Bridged	H-Bond	a	Asp102-OD2	 O1	 1	 2.8	 Hydrogen	Bond	Tyr63-OH:HOH-O	 O3	 1	 3.3	 Bridged	H-Bond	a	
D-Galp-II	 	 	 	 	Asp102-OD2	 O20	 2	 2.6	 Hydrogen	Bond	Tyr63-OH	 O7	 2	 2.5	 Hydrogen	Bond	Gly105-O/N/Val99-O:HOH-O	 O20	 2	 2.7	 Bridged	H-Bond	a	Gln104-NE2	 O9	 2	 3.3	 Hydrogen	Bond	Gly105-O/N/Val99-O:HOH-O	 O9	 2	 2.8	 Bridged	H-Bond	a	
D-Galf-III	 	 	 	 	Trp64-NE1	 O19	 3	 2.9	 Hydrogen	Bond	Ala108-O:HOH-O	 O13	 3	 3.3	 Bridged	H-Bond	a	Asn60-OD1/O:HOH-O	 O11	 3	 2.8	 Bridged	H-Bond	a	Asp49-OD2:HOH-O	 O11	 3	 3.2	 Bridged	H-Bond	a	Gly105-O/N/Val99-O:HOH-O	 O19	 3	 2.7	 Bridged	H-Bond	a	Asn60-OD1/Asp49-OD2:HOH-O	 O11	 3	 3.2	 Bridged	H-Bond	a	
D-Galp-IV	 	 	 	 	Trp109-CA	 C20	 4	 3.9	 Hydrophobic	Trp109-CD1	 C19	 4	 3.3	 Hydrophobic	Trp109-CE2	 C18	 4	 3.7	 Hydrophobic	Trp109-CG	 C19	 4	 3.7	 Hydrophobic	Gln58-O	 O16	 4	 3.1	 Hydrogen	Bond	Asn60-CB	 C16	 4	 3.8	 Hydrophobic	Asn60-N	 O15	 4	 2.8	 Hydrogen	Bond	Trp64-CD1	 C18	 4	 3.9	 Hydrophobic	Asp53-OD2:HOH-O	 O16	 4	 2.6	 Bridged	H-Bond	a	Asp53-OD2:HOH-O	 O17	 4	 2.6	 Bridged	H-Bond	a	Asp53-OD2:HOH-O	 O18	 4	 3.5	 Bridged	H-Bond	a	Glu35-OE2/Val110-N/Ala111-N:HOH-O	 O17	 4	 2.6	 Bridged	H-Bond	a	Glu35-OE1:HOH-O	 O16	 4	 2.6	 Bridged	H-Bond	a	Asn60-OD1:HOH-O	 O18	 4	 3.1	 Bridged	H-Bond	a	
 
a) The given distance for bridged hydrogen bonds is the distance of the bridging water oxygen to 
the next atom of the tetrasaccharide 2. 
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Chapter II: Molecular and medical basis of protein – carbohydrate 
interactions under special consideration of sialic acids 
 
1. Introduction 
 
1.1  Sialic acids 
Sialic acids (Sia), are a group of derivatives of acidic nine carbon monosaccharides, which are 
frequently located at the end of glycan chains and as major components of glycoproteins, 
glycolipids and mucins. In 1952, in an article to present galactosamine existing in brain 
gangliosides and which acts as the main carbohydrate of submaxillary mucin, Gunnar Blix and 
his colleagues first used the term “sialic acid“ to describe the partially characterized structure42. 
The biosynthesis of sialic acids starting from glucose in the cytosol, then Neu5Ac-9-phosphate 
is activated in the nucleus by a cytidine monophosphate (CMP) residue through CMP-Neu5Ac 
synthase. Then CMP-Neu5Ac is transferred onto glycoconjugates in Golgi apparatus, followed 
by the vesicular transport of sialylated glycoconjugates to the plasma membrane. In the sialic 
acids catabolism process, the sialidases play a very important role. It can cause the removal of 
sialic acid residues from the cell surface or serum sialoglycoconjugates43. So far, more than 50 
Sia naturally occurring members have been identified in this large family, which mainly derives 
from multiple substituents at C-4, C-5, C-7, C-8 and C-9 positions (Fig. 5). Among these 
diversities, C-5 decorated with acetamido (Neu5Ac) and, hydroxyacetamido (Neu5Gc) and 
hydroxyl group contribute much to Sia structural variations. These decorations may combine 
with the substituents of any of the hydroxyl groups positioned at C-4, C-7, C-8 and C-9, such 
as, the modifications of C-8 with methyl or sulfate moieties and C-9 with lactyl or phosphoryl 
residues etc43-46. Neu5Ac is the most widely distributed and the best-researched molecule of 
the Sia family, while Neu5Gc, and N-acetyl-9-O-acetylneuraminic acid (Neu5, 9Ac2) are the 
following most frequently occurring sialic acids in nature. Sia are found at all cell surfaces of 
vertebrates and some invertebrates, and are also widely reported in other organisms, ranging 
from plants, insects and microorganisms47,48. The diversity of Sia structures and its wide 
distributed closely link with its variety of biological functions, e.g. biological recognition 
processes, fertilization (egg-sperm interaction), development (brain, nervous system) and 
immune regulation as well as cancer and infections (virus, bacterium, protozoa and fungi 
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infection)44,49, Fig. 6.  
 
 
Fig. 5. The family of naturally occurring Sia44. 
 
 
Fig. 6. Sia frequently occurring at the end of glycan chains as major compositions of glycoproteins and glycolipids, 
take part in many biological recognition processes49. 
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1.2 Polysialic acid 
Polysialic acid (polySia, PSA) is a homopolymer of sialic acid in α-2,8 or α-2,9 linkages or a 
combination of α-2,8 and α-2,9. It was first identified in E. coli (Escherichia coli) K-1 and K-235 
by Barry49. Subsequent studies have discovered that PSA is predominantly attached to the 
protein backbone of the neural cell adhesion molecule (NCAM) of vertebrates51. Since polySia 
are located at cell surfaces, they have evolved dual functions, ‘protector’ and ‘counter-receptor’ 
or ligand. On the one hand, they mask cells or recognition sites to protect cells from attacking, 
e.g. the overexpression of polySia on the cell surfaces of many tumors like malignant gliomas, 
small cell lung cancer and neuroblastomas enables tumor cells to keep an undifferentiated 
state and therefore to exist outside of the cellular “social network” and grow irrespective of 
regulating factors expressed by the neighbouring cells52-59. On the other hand, they act as 
biological ligand and are recognized by numerous receptor proteins or lectins from different 
origin48. In addition, Sia interacting with the same binding partners at different organs may play 
different biological functions. For example, in the respiratory and reproductive systems, 
polySia attached to NCAM is discussed to counteract the cytotoxic characteristics of 
extracellular histones, which are generated during inflammation60,61. In contrast, in the 
neuronal system the interaction of polySia with histone H1 seems to be important for 
regeneration phenomena. Histone H1 directly binds to polySia at an extracellular position as 
shown for cultured cerebellar neurons. Immunostaining of live cerebellar neurons and 
Schwann cells confirmed that an extracellular pool of histone H1 colocalises with polySia at 
the cell surface and stimulates neuritogenesis and process formation as well as proliferation of 
Schwann cells in vitro. Furthermore, migration of neural precursor cells via a polySia-
dependent mechanism also indicates that histone H1 is active extracellularly. These in vitro 
observations suggest an important functional role for the interaction between histone H1 and 
polySia not only for nervous system development but also for regeneration in the adult. Indeed, 
histone H1 improved functional recovery, axon regrowth, and precision of reinnervation of the 
motor branch in adult mice with femoral nerve injury62. 
1.3 Sialic acid binding partners 
The most well-known Sia binding partners are viral capsid proteins, siglecs, selectins, 
sialidases and sialyl-transferases. These naturally occurring sialic-acid-binding lectins are 
widely found in virus, bacteria, protozoa, fungi, plant, as well as invertebrate and vertebrate63,64. 
Sialic acid receptors of diverse origin belong to different sequence families and fold classes. 
However, when focused on the binding site level, these lectins share structural similarities in 
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the architecture and geometry of the carbohydrate recognition domains (CRDs). This binding 
property of Sia is the same as binding behaviors of other saccharide ligand, e.g. mannose, 
glucose and galactose65,66. Utilizing the bioinformatics methods, Raghu Bhagavat and 
Nagasuma Chandra recently analyzed the common recognition principles of sialic acid binding 
proteins in the Protein Data Bank. The results indicated that the Sia binding sites of proteins 
with diverse amino acid sequences and structural features could be classified into only six 
structural clusterings, which are composed of one or more different combinations of the basic 
structural features over a common scaffold (Fig. 7). Moreover, among all these Sia interacting 
amino acid residues, tyrosine, arginine and aspartic acid were frequently found to be present 
in most binding architectures67. 
 
 
Fig. 7. Key binding site features existing in different combinations for the six site types identified are shown. 
Residues that belong to each feature are mentioned with their residue numbers (as in the reference site)67. 
 
2.  Experimental research 
 
2.1 Research proposals and methods 
Sialic acids and especially the α2, 8-linked Neu5Ac residues (scheme 1) are involved in 
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diverse cell differentiation processes depending on the organ, the cell type and the stage of 
maturation68-73. When the impact of certain epitopes on these processes is analyzed with the 
aim of therapeutical improvements it is essential to describe the glycan-receptor interaction at 
atomic level. Therefore, it is important to determine the crucial functional groups on the ligand 
and on the receptor side as well as the positions of these functional groups located to each 
other. Since drug analysis and drug design are our goals we have looked for common 
principles, which are characteristic for these ligand - receptor interactions under study. 
Here we applied a combination of NMR, molecular modelling (including docking algorithms as 
well as quantum chemical calculations) strategy to examine the interaction of polySia and 
sulfated polysaccharides with their cognate receptors on a sub-molecular level. In our study 
we are focusing on the polySia receptors, the myristoylated alanine-rich C kinase substrate 
(MARCKS), the α-defensins HNP1,2,3 and HD5 as well as the lectin from the Chinese bird 
hunting spider, SHL-1 (Selenocosmia huwena Lectin-I) to describe the molecular basis of 
polySia – protein interaction. 
 
Scheme 1: Illustration of a sialic acid tetramer consisting of four α2, 8-linked Neu5Ac residues. 
 
2.2  Main experimental results 
1) Data mining approaches for a general analysis of all protein - sialic acid complexes in the 
Protein Data Bank (PDB) show that Arg (R), Tyr (Y) and Trp (W) residues are the most 
frequently occurring amino acid residues in the vicinity of bound sialic acids. 
2) Our NMR results clearly indicate that the addition of polySia to the MARCKS-ED peptide 
causes spectral changes, suggesting that protons from the MARCKS-ED peptide are involved 
in binding with polySia. 
3) When focusing on sulfate groups of glycan, the data mining approach shows that Lys (K) is 
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overrepresented in the vicinity of this functional group. Besides Lys (K) residues, Arg (R) 
residues are likely to primarily bind due to their vicinity preferably to sulfate groups and uronic 
acid. 
4) Arg (R) and Asn (N) are overrepresented as well as the aromatic amino acid residues Tyr 
(Y) and Trp (W) when uronic acids are bound to the carbohydrate recognition domain (CRD) of 
their respective receptors. 
5) NMR experiments using SHL-1 or the human α-defensins HNP1,2,3 as receptors and 
polySia fragments from colominic acid as ligands revealed that three aromatic amino acid 
residues and one Arg residue play a major role in carbohydrate binding. 
6) Compared to a control group (poly-L-lysine), the sulfated polysaccharides from algae show 
a statistically significant enhancement of neurite outgrowth at concentrations from 0.0001 to 
0.1 mg/ml. However, at concentrations that were higher than 1 mg/ml, the sulfated 
polysaccharides exhibit inhibitory effects on neurite outgrowth. 
My major contribution to this study was to carry out the NMR experiments, molecular modelling 
analysis and testing the influence of sulfated polysaccharides from algae origin on neurite 
outgrowth as well as the analyses of the related results of these studies. 
 
3.  Research manuscripts 
The detailed experimental methods, material, results as well as conclusion are presented in 
our following three manuscripts. 	
3.1 Molecular basis of the receptor interactions of polysialic acid (polySia), polySia 
mimetics, and sulfated polysaccharides (Published in ChemMedChem, 2016; 
DOI: 10.1002/cmdc.201500609) 
 
3.2 Structure-function relationships of antimicrobial peptides and proteins with respect 
to contact molecules on pathogen surfaces (Published in Current Topics in Medicinal 
Chemistry, 2015; DOI: 10.2174/1568026615666150703120753) 
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3.3 Interaction studies of sialic acids with model receptors contribute to nanomedical 
therapies (Published in Journal of Neurological Disorders, 2015; DOI: 10.4172/2329-
6895.1000212) 
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3.1 Molecular basis of the receptor interactions of polysialic acid (polySia), polySia 
mimetics, and sulfated polysaccharides 
 
My contribution for this publication was to carry out the NMR, Molecular modelling experiments 
and analyse the related results, as well as test the impact of sulfated polysaccharides on the 
migration of primary neurons from cerebellar explants. 
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3.2 Structure-function relationships of antimicrobial peptides and proteins with respect 
to contact molecules on pathogen surfaces 
 
My contribution for this publication was to carry out Molecular modelling experiments and to 
analyse the related results. 
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3.3 Interaction studies of sialic acids with model receptors contribute to nanomedical 
therapies 
 
My contribution for this publication was to perform the NMR and Molecular modelling 
experiments and to analyse the related results. 
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Chapter III: The analysis of molecular weight distribution of hyaluronic 
acid with ImageJ 
 
1. Introduction 	
1.1 Hyaluronic acid 
Hyaluronic acid (HA), also named hyaluronan, is a long chain, non-sulfated 
glycosaminoglycan. It consists of the disaccharide repeating units, D-glucuronic acid and N-
acetyl D-glucosamine (Fig. 8). HA is a major extracellular matrix component in cartilage, 
synovial fluid (SF), eye fluid, epithelial and vitreous humor, as well as various tissues, 
including brain, kidney, nerve and muscle74-76. Accompanied with its wide distribution, HA 
also plays a multiple role in different biological processes. For example, tissue hydration, 
lubrication, and interactions with proteins and proteoglycans, as well as mediating signaling 
pathways etc76-79. HA has a broad molecular weight (MW) distribution, in human SF, it ranges 
from 27 kDa to 10 MDa, with the average of 3 MDa - 4 MDa80-83. It was indicated that HA in 
SF from patient knee joints with advanced osteoarthritis degraded to the lower MW 
glycosaminoglycan, because of enzymatic cleavage of HA long chains84. 
 
 
Fig. 8. Hyaluronic acid molecular formula. Picture derived from Wikipedia 
(https://en.wikipedia.org/wiki/Hyaluronic_acid). 	
1.2 ImageJ software program  
ImageJ is a Java-based, freely accessible public domain software tool for image processing 
and analyzing (Fig. 9). It was initially called NIH Image, developed by Wayne Rasband at the 
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National Institutes of Health, in 1987. About 10 years later, when he decided to use Java as 
the programming language of NIH Image, he renamed the software as ImageJ, with a “J” to 
represent its Java property. ImageJ has many features that make it very popular and thrived 
during the last three decades85,86. Parts of these advantages are shown as following: 
1) ImageJ is a public domain and open source program. Combined with its Java source code, 
macros and plugins, one can freely download the program from its official website 
(http://rsb.info.nih.gov/ij/download.html). 
2) It is available for most operating systems, such as Macintosh, Linux, Windows, and PDA, 
in both, 32-bit and 64-bit architecture. 
3) It can read, manipulate and analyze lots of different kind of image file formats, including 
GIF, JPEG, BMP, PNG, PGM, FITS, ASCII, TIFF, and raw data. 
4) ImageJ has many image processing and analyzing functions, e.g. image enhancement, 
geometric transformations, color handling, measuring distances, angles, areas and pixel 
values etc. It has been widely used by researchers in life sciences. 
5) In addition, ImageJ has an inter-disciplinary community worldwide. So far, there exist more 
than 1700 experts in the ImageJ mailing list. They contribute to knowledgeable 
discussions and solutions regarding the applications of ImageJ in various scientific fields.  
For more details concerning ImageJ software program, one can visit its official website 
(http://rsb.info.nih.gov/ij/index.html). 
 
Fig. 9. ImageJ software interface and some of its function representations. The figure derived from ImageJ 
official website (http://rsb.info.nih.gov/ij/docs/concepts.html). 
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2. Analysis of hyaluronic acid molecular weight distribution with ImageJ 
 
One of our experiments is focused on the testing of the collective levels of HA, in SF patients 
with common joint diseases (e.g. early-or late-stage osteoarthritis). Hyaluronic acids from 
these patients were purified and separated based on their molecular weight using agarose 
gel electrophoresis followed by staining (The gels were stained overnight using 0.005% 
Stains-All (Sigma-Aldrich, Taufkirchen, Germany) in 50% ethanol and destained with 10% 
ethanol for a minimum of 24 h.).  
My contribution in this study project has been the development of a new ImageJ analyzing 
method, to determine the molecular weight distribution of HA.  
The molecular weight distribution of HA forms according to its markers being commercially 
available (<0.5, 0.5–1.1, 1.1–3.1, 3.1–6.1, >6.1 MDa) was determined densitometrically. The 
detailed processing and analyzing steps of HA images from agarose gel electrophoresis are 
summerized below: 
ImageJ analyzing protocol 
Since its broad MW distribution, the continuous bands of HA were obtained from agarose gel 
electrophoresis. However, it is not available for ImageJ to analyze the corresponding images 
with the common methods that have been used for analyzing separated bands. Therefore, 
we developed a new method based on ImageJ functionality after a specific processing of the 
images. 
1) Open the ImageJ software and load the raw HA image (Fig. a). 
2) Use the Image → Transform → Rotate 90 Degrees Right tool to rotate the image (Fig. 
b). 
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                              Fig. a Raw HA image 
 
 
 
                                Fig. b After 90 degrees clockwise rotation. 
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3) Select the Edit → Invert tool to invert the image. 
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4) Select the rectangular selection tool on the left side of the tool menu. 
	
 
 
 
5) Draw the rectangle in the region where we want to measure (e.g. MW 3.1KDa-6.1KDa). 
Then click Analyze → Gels → SelectFirst Lane (or “control+1” in Windows).  
 
 
 
  91	
6) Choose Analyze → Gels → Plot Lanes (or “control+3” in Windows). A window will pop 
open. It is the densitometry measurements interface, which gives a graphical depiction of 
the average intensity of pixels from the top of the rectangle to the bottom. 
 
 
7) To measure the density of bands, one just needs to measure the area under the peak 
(subtracting the background noise) from this plot. To do so, select the straight-line tool 
from the main menu to close off all peaks. 
 
 
 
 Close	off	the	peak	
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8) Using the wand (tracing) tool to click on each peak. The peaks will be yellow outlined. 
This step integrates the area under the curve of each peak. After that another “Results” 
window will be shown automatically. 
 
 
 
 
9) The values appearing in this Results window are the areas of peaks. These values are 
related to the band intensity of each lane, and could subsequently present the amounts of 
substance (e.g. HA) that were loaded into each well. 
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3. Research paper 
We have applied this ImageJ protocol to analyze the MW distribution of HA in SF and 
published a paper as below:  
 
3.1 Articular joint lubricants during osteoarthritis and rheumatoid arthritis display 
altered levels and molecular species 
(Published in PLoS One, 2015; DOI: 10.1371/journal.pone.0125192) 
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